The Journal of allergy and clinical immunology
-
J. Allergy Clin. Immunol. · Oct 2004
Randomized Controlled Trial Multicenter Study Clinical TrialCoseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
We wondered whether short-term coseasonal sublingual immunotherapy (SLIT) can reduce the development of asthma in children with hay fever in an open randomized study. ⋯ Three years of coseasonal SLIT improves seasonal allergic rhinitis symptoms and reduces the development of seasonal asthma in children with hay fever.